Polymyositis as a manifestation of chronic graft-versus-host disease
…, JC Niland, CA Linker, BS Greffe, A Kashyap… - Medicine, 1996 - journals.lww.com
Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic
bone mar-row transplantation (BMT) and is caused by an immunologic reaction against …
bone mar-row transplantation (BMT) and is caused by an immunologic reaction against …
[HTML][HTML] Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers
…, R Clift, SJ Forman, R Negrin, A Kashyap… - … England Journal of …, 2001 - Mass Medical Soc
Background In recipients of allogeneic hematopoietic-cell transplants, peripheral-blood
cells mobilized with the use of filgrastim (recombinant granulocyte colony-stimulating factor) …
cells mobilized with the use of filgrastim (recombinant granulocyte colony-stimulating factor) …
Solid cancers after bone marrow transplantation
…, MR O'Donnell, H Fung, A Kashyap… - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: To evaluate the incidence and associated risk factors of solid cancers after bone
marrow transplantation (BMT). PATIENTS AND METHODS: We analyzed 2,129 patients …
marrow transplantation (BMT). PATIENTS AND METHODS: We analyzed 2,129 patients …
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
We analyzed data on 612 patients who had undergone high-dose chemoradiotherapy (HDT)
with autologous stem cell rescue for Hodgkin's disease (HD) and non-Hodgkin's lymphoma …
with autologous stem cell rescue for Hodgkin's disease (HD) and non-Hodgkin's lymphoma …
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased …
A Kashyap, J Wingard, P Cagnoni, R Jones… - Biology of blood and …, 2002 - tctjournal.org
Hepatic venoocclusive disease (HVOD) is a complication of allogeneic hematopoietic stem
cell transplantation (HSCT) and is a well-recognized dose-limiting toxicity of oral busulfan (Bu…
cell transplantation (HSCT) and is a well-recognized dose-limiting toxicity of oral busulfan (Bu…
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase …
BS Andersson, A Kashyap, V Gian… - Biology of Blood and …, 2002 - astctjournal.org
Busulfan (Bu) is commonly used as a component of conditioning regimens for hematopoietic
stem cell transplantation. Precise delivery of the oral formulation is compromised by erratic …
stem cell transplantation. Precise delivery of the oral formulation is compromised by erratic …
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
…, I Espigado, E Jantunen, A Kashyap… - The Journal of …, 2004 - jrheum.org
OBJECTIVE: Since 1996, autologous hemopoietic stem cell transplantation (HSCT) has
been used to treat severe rheumatoid arthritis (RA). To date, published reports have been …
been used to treat severe rheumatoid arthritis (RA). To date, published reports have been …
Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring
H Openshaw, BT Lund, A Kashyap, R Atkinson… - Biology of Blood and …, 2000 - Elsevier
Multiple sclerosis (MS) is an immune-mediated disease that may be amenable to high-dose
immunosuppression with peripheral blood stem cell transplantation (SCT) in selected …
immunosuppression with peripheral blood stem cell transplantation (SCT) in selected …
Autologous bone marrow transplantation for non‐Hodgkin's lymphoma resulting in long‐term remission of coincidental Crohn's disease
A Kashyap, SJ Forman - British journal of haematology, 1998 - Wiley Online Library
Crohn's disease usually runs a chronic relapsing and remitting course, characterized by a
repeated need for immunosuppressive drug therapy or often surgery, and is considered to be …
repeated need for immunosuppressive drug therapy or often surgery, and is considered to be …
Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate-and high-grade lymphoma …
…, A Stein, E Smith, I Planás, A Kashyap… - Blood, The Journal …, 1997 - ashpublications.org
We have conducted a pilot study to investigate the role of high-dose therapy and autologous
bone marrow/stem cell transplantation (ASCT) during first complete or partial remission in …
bone marrow/stem cell transplantation (ASCT) during first complete or partial remission in …